uniQure: AMT-130 For HD Progresses Forward With Q2 2025 FDA Meeting #uniQure #AMT130 #Progresses #FDA #Meeting
Tag: UniQure
UniQure N.V. (QURE) Soars on FDA Breakthrough Therapy Designation for Huntington’s Disease Treatment
As of this writing, UniQure N.V.’s stock price has surged 35.89% to $12.79 per share after…